| | | |
SFA 12wk
|
|---|
| |
↓
| |
|---|
| |
LF 12wk
|
SFA 12wk
|
LF + At 2wk
|
SFA + At 2wk
|
LF + Pr 2wk
|
SFA + Pr 2wk
|
LF + Ib 2wk
|
SFA + Ib 2wk
|
|---|
|
Cholesterol (mM)
|
1.83 ± 0.20
|
1.54 ± 0.20
|
1.68 ± 0.11
|
1.69 ± 0.05
|
1.64 ± 0.13
|
1.91 ± 0.13
|
1.93 ± 0.12
|
1.59 ± 0.13
|
|
Triglycerides (mM)
|
0.74 ± 0.08
|
0.34 ± 0.04a
|
0.39 ± 0.03a
|
0.34 ± 0.02a
|
0.36 ± 0.01a
|
0.40 ± 0.04a
|
0.42 ± 0.03a
|
0.31 ± 0.02a
|
|
NEFA (mEq/L)
|
0.85 ± 0.08
|
0.68 ± 0.04
|
0.93 ± 0.05
|
0.82 ± 0.04
|
1.02 ± 0.05b
|
0.90 ± 0.08
|
1.05 ± 0.10b
|
0.79 ± 0.05
|
- The table shows the effects of various feeding regimens on plasma lipids. Plasma total cholesterol, triglycerides and non-esterified fatty acids (NEFA) were measured at the end of the feeding regimen. Data represented as mean ± standard error of mean. Means were compared with non-parametric independent t test, where P < 0.05 considered statistically significant.
- a: statistically significant in comparison to LF;
- b: statistically significant in comparison to SFA.
- Abbreviations: LF, low-fat; SFA, saturated fatty acids; At, atorvastatin; Pr, pravastatin; Ib, ibuprofen; wk, weeks.
